img

Global Oral COVID-19 Vaccine Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Oral COVID-19 Vaccine Market Insights, Forecast to 2034

Global Oral COVID-19 Vaccine market is expected to reach to US$ 889 million in 2024, with a positive growth of %, compared with US$ 842 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Oral COVID-19 Vaccine industry is evaluated to reach US$ 1211.9 million in 2029. The CAGR will be 5.3% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Oral COVID-19 Vaccine market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Oral COVID-19 Vaccine market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Pfizer
CanSino Biologics
Kindred Biosciences, Inc.
Zhejiang Huahai Pharmaceutical Co.,ltd.
Shandong Xinhua Pharmaceutical
Kintor Pharmaceutical
Henan Genuine Biotech Co., Ltd.
Segment by Type
Tablet Type
Inhalable Type

Segment by Application


Adults
Children
Elderly

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Oral COVID-19 Vaccine plant distribution, commercial date of Oral COVID-19 Vaccine, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Oral COVID-19 Vaccine introduction, etc. Oral COVID-19 Vaccine Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Oral COVID-19 Vaccine
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Oral COVID-19 Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Oral COVID-19 Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Tablet Type
1.2.3 Inhalable Type
1.3 Market by Application
1.3.1 Global Oral COVID-19 Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Adults
1.3.3 Children
1.3.4 Elderly
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Oral COVID-19 Vaccine Sales Estimates and Forecasts 2018-2029
2.2 Global Oral COVID-19 Vaccine Revenue by Region
2.2.1 Global Oral COVID-19 Vaccine Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Oral COVID-19 Vaccine Revenue by Region (2018-2024)
2.2.3 Global Oral COVID-19 Vaccine Revenue by Region (2024-2029)
2.2.4 Global Oral COVID-19 Vaccine Revenue Market Share by Region (2018-2029)
2.3 Global Oral COVID-19 Vaccine Sales Estimates and Forecasts 2018-2029
2.4 Global Oral COVID-19 Vaccine Sales by Region
2.4.1 Global Oral COVID-19 Vaccine Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Oral COVID-19 Vaccine Sales by Region (2018-2024)
2.4.3 Global Oral COVID-19 Vaccine Sales by Region (2024-2029)
2.4.4 Global Oral COVID-19 Vaccine Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Oral COVID-19 Vaccine Sales by Manufacturers
3.1.1 Global Oral COVID-19 Vaccine Sales by Manufacturers (2018-2024)
3.1.2 Global Oral COVID-19 Vaccine Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Oral COVID-19 Vaccine in 2022
3.2 Global Oral COVID-19 Vaccine Revenue by Manufacturers
3.2.1 Global Oral COVID-19 Vaccine Revenue by Manufacturers (2018-2024)
3.2.2 Global Oral COVID-19 Vaccine Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Oral COVID-19 Vaccine Revenue in 2022
3.3 Global Key Players of Oral COVID-19 Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Oral COVID-19 Vaccine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Oral COVID-19 Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Oral COVID-19 Vaccine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Oral COVID-19 Vaccine, Product Offered and Application
3.8 Global Key Manufacturers of Oral COVID-19 Vaccine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Oral COVID-19 Vaccine Sales by Type
4.1.1 Global Oral COVID-19 Vaccine Historical Sales by Type (2018-2024)
4.1.2 Global Oral COVID-19 Vaccine Forecasted Sales by Type (2024-2029)
4.1.3 Global Oral COVID-19 Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Oral COVID-19 Vaccine Revenue by Type
4.2.1 Global Oral COVID-19 Vaccine Historical Revenue by Type (2018-2024)
4.2.2 Global Oral COVID-19 Vaccine Forecasted Revenue by Type (2024-2029)
4.2.3 Global Oral COVID-19 Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Oral COVID-19 Vaccine Price by Type
4.3.1 Global Oral COVID-19 Vaccine Price by Type (2018-2024)
4.3.2 Global Oral COVID-19 Vaccine Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Oral COVID-19 Vaccine Sales by Application
5.1.1 Global Oral COVID-19 Vaccine Historical Sales by Application (2018-2024)
5.1.2 Global Oral COVID-19 Vaccine Forecasted Sales by Application (2024-2029)
5.1.3 Global Oral COVID-19 Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Oral COVID-19 Vaccine Revenue by Application
5.2.1 Global Oral COVID-19 Vaccine Historical Revenue by Application (2018-2024)
5.2.2 Global Oral COVID-19 Vaccine Forecasted Revenue by Application (2024-2029)
5.2.3 Global Oral COVID-19 Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Oral COVID-19 Vaccine Price by Application
5.3.1 Global Oral COVID-19 Vaccine Price by Application (2018-2024)
5.3.2 Global Oral COVID-19 Vaccine Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Oral COVID-19 Vaccine Market Size by Type
6.1.1 US & Canada Oral COVID-19 Vaccine Sales by Type (2018-2029)
6.1.2 US & Canada Oral COVID-19 Vaccine Revenue by Type (2018-2029)
6.2 US & Canada Oral COVID-19 Vaccine Market Size by Application
6.2.1 US & Canada Oral COVID-19 Vaccine Sales by Application (2018-2029)
6.2.2 US & Canada Oral COVID-19 Vaccine Revenue by Application (2018-2029)
6.3 US & Canada Oral COVID-19 Vaccine Market Size by Country
6.3.1 US & Canada Oral COVID-19 Vaccine Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Oral COVID-19 Vaccine Sales by Country (2018-2029)
6.3.3 US & Canada Oral COVID-19 Vaccine Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Oral COVID-19 Vaccine Market Size by Type
7.1.1 Europe Oral COVID-19 Vaccine Sales by Type (2018-2029)
7.1.2 Europe Oral COVID-19 Vaccine Revenue by Type (2018-2029)
7.2 Europe Oral COVID-19 Vaccine Market Size by Application
7.2.1 Europe Oral COVID-19 Vaccine Sales by Application (2018-2029)
7.2.2 Europe Oral COVID-19 Vaccine Revenue by Application (2018-2029)
7.3 Europe Oral COVID-19 Vaccine Market Size by Country
7.3.1 Europe Oral COVID-19 Vaccine Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Oral COVID-19 Vaccine Sales by Country (2018-2029)
7.3.3 Europe Oral COVID-19 Vaccine Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Oral COVID-19 Vaccine Market Size
8.1.1 China Oral COVID-19 Vaccine Sales (2018-2029)
8.1.2 China Oral COVID-19 Vaccine Revenue (2018-2029)
8.2 China Oral COVID-19 Vaccine Market Size by Application
8.2.1 China Oral COVID-19 Vaccine Sales by Application (2018-2029)
8.2.2 China Oral COVID-19 Vaccine Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Oral COVID-19 Vaccine Market Size by Type
9.1.1 Asia Oral COVID-19 Vaccine Sales by Type (2018-2029)
9.1.2 Asia Oral COVID-19 Vaccine Revenue by Type (2018-2029)
9.2 Asia Oral COVID-19 Vaccine Market Size by Application
9.2.1 Asia Oral COVID-19 Vaccine Sales by Application (2018-2029)
9.2.2 Asia Oral COVID-19 Vaccine Revenue by Application (2018-2029)
9.3 Asia Oral COVID-19 Vaccine Sales by Region
9.3.1 Asia Oral COVID-19 Vaccine Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Oral COVID-19 Vaccine Revenue by Region (2018-2029)
9.3.3 Asia Oral COVID-19 Vaccine Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Oral COVID-19 Vaccine Market Size by Type
10.1.1 Middle East, Africa and Latin America Oral COVID-19 Vaccine Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Oral COVID-19 Vaccine Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Oral COVID-19 Vaccine Market Size by Application
10.2.1 Middle East, Africa and Latin America Oral COVID-19 Vaccine Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Oral COVID-19 Vaccine Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Oral COVID-19 Vaccine Sales by Country
10.3.1 Middle East, Africa and Latin America Oral COVID-19 Vaccine Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Oral COVID-19 Vaccine Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Oral COVID-19 Vaccine Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Oral COVID-19 Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Pfizer Oral COVID-19 Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 CanSino Biologics
11.2.1 CanSino Biologics Company Information
11.2.2 CanSino Biologics Overview
11.2.3 CanSino Biologics Oral COVID-19 Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 CanSino Biologics Oral COVID-19 Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 CanSino Biologics Recent Developments
11.3 Kindred Biosciences, Inc.
11.3.1 Kindred Biosciences, Inc. Company Information
11.3.2 Kindred Biosciences, Inc. Overview
11.3.3 Kindred Biosciences, Inc. Oral COVID-19 Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Kindred Biosciences, Inc. Oral COVID-19 Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Kindred Biosciences, Inc. Recent Developments
11.4 Zhejiang Huahai Pharmaceutical Co.,ltd.
11.4.1 Zhejiang Huahai Pharmaceutical Co.,ltd. Company Information
11.4.2 Zhejiang Huahai Pharmaceutical Co.,ltd. Overview
11.4.3 Zhejiang Huahai Pharmaceutical Co.,ltd. Oral COVID-19 Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Zhejiang Huahai Pharmaceutical Co.,ltd. Oral COVID-19 Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Zhejiang Huahai Pharmaceutical Co.,ltd. Recent Developments
11.5 Shandong Xinhua Pharmaceutical
11.5.1 Shandong Xinhua Pharmaceutical Company Information
11.5.2 Shandong Xinhua Pharmaceutical Overview
11.5.3 Shandong Xinhua Pharmaceutical Oral COVID-19 Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Shandong Xinhua Pharmaceutical Oral COVID-19 Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Shandong Xinhua Pharmaceutical Recent Developments
11.6 Kintor Pharmaceutical
11.6.1 Kintor Pharmaceutical Company Information
11.6.2 Kintor Pharmaceutical Overview
11.6.3 Kintor Pharmaceutical Oral COVID-19 Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Kintor Pharmaceutical Oral COVID-19 Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Kintor Pharmaceutical Recent Developments
11.7 Henan Genuine Biotech Co., Ltd.
11.7.1 Henan Genuine Biotech Co., Ltd. Company Information
11.7.2 Henan Genuine Biotech Co., Ltd. Overview
11.7.3 Henan Genuine Biotech Co., Ltd. Oral COVID-19 Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Henan Genuine Biotech Co., Ltd. Oral COVID-19 Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Henan Genuine Biotech Co., Ltd. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Oral COVID-19 Vaccine Industry Chain Analysis
12.2 Oral COVID-19 Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Oral COVID-19 Vaccine Production Mode & Process
12.4 Oral COVID-19 Vaccine Sales and Marketing
12.4.1 Oral COVID-19 Vaccine Sales Channels
12.4.2 Oral COVID-19 Vaccine Distributors
12.5 Oral COVID-19 Vaccine Customers
13 Market Dynamics
13.1 Oral COVID-19 Vaccine Industry Trends
13.2 Oral COVID-19 Vaccine Market Drivers
13.3 Oral COVID-19 Vaccine Market Challenges
13.4 Oral COVID-19 Vaccine Market Restraints
14 Key Findings in The Global Oral COVID-19 Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Oral COVID-19 Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Tablet Type
Table 3. Major Manufacturers of Inhalable Type
Table 4. Global Oral COVID-19 Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Oral COVID-19 Vaccine Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Oral COVID-19 Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Oral COVID-19 Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Oral COVID-19 Vaccine Revenue Market Share by Region (2018-2024)
Table 9. Global Oral COVID-19 Vaccine Revenue Market Share by Region (2024-2029)
Table 10. Global Oral COVID-19 Vaccine Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Oral COVID-19 Vaccine Sales by Region (2018-2024) & (K Units)
Table 12. Global Oral COVID-19 Vaccine Sales by Region (2024-2029) & (K Units)
Table 13. Global Oral COVID-19 Vaccine Sales Market Share by Region (2018-2024)
Table 14. Global Oral COVID-19 Vaccine Sales Market Share by Region (2024-2029)
Table 15. Global Oral COVID-19 Vaccine Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Oral COVID-19 Vaccine Sales Share by Manufacturers (2018-2024)
Table 17. Global Oral COVID-19 Vaccine Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Oral COVID-19 Vaccine Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Oral COVID-19 Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Oral COVID-19 Vaccine Price by Manufacturers 2018-2024 (US$/Unit)
Table 21. Global Oral COVID-19 Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Oral COVID-19 Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral COVID-19 Vaccine as of 2022)
Table 23. Global Key Manufacturers of Oral COVID-19 Vaccine, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Oral COVID-19 Vaccine, Product Offered and Application
Table 25. Global Key Manufacturers of Oral COVID-19 Vaccine, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Oral COVID-19 Vaccine Sales by Type (2018-2024) & (K Units)
Table 28. Global Oral COVID-19 Vaccine Sales by Type (2024-2029) & (K Units)
Table 29. Global Oral COVID-19 Vaccine Sales Share by Type (2018-2024)
Table 30. Global Oral COVID-19 Vaccine Sales Share by Type (2024-2029)
Table 31. Global Oral COVID-19 Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Oral COVID-19 Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Oral COVID-19 Vaccine Revenue Share by Type (2018-2024)
Table 34. Global Oral COVID-19 Vaccine Revenue Share by Type (2024-2029)
Table 35. Oral COVID-19 Vaccine Price by Type (2018-2024) & (US$/Unit)
Table 36. Global Oral COVID-19 Vaccine Price Forecast by Type (2024-2029) & (US$/Unit)
Table 37. Global Oral COVID-19 Vaccine Sales by Application (2018-2024) & (K Units)
Table 38. Global Oral COVID-19 Vaccine Sales by Application (2024-2029) & (K Units)
Table 39. Global Oral COVID-19 Vaccine Sales Share by Application (2018-2024)
Table 40. Global Oral COVID-19 Vaccine Sales Share by Application (2024-2029)
Table 41. Global Oral COVID-19 Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Oral COVID-19 Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Oral COVID-19 Vaccine Revenue Share by Application (2018-2024)
Table 44. Global Oral COVID-19 Vaccine Revenue Share by Application (2024-2029)
Table 45. Oral COVID-19 Vaccine Price by Application (2018-2024) & (US$/Unit)
Table 46. Global Oral COVID-19 Vaccine Price Forecast by Application (2024-2029) & (US$/Unit)
Table 47. US & Canada Oral COVID-19 Vaccine Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Oral COVID-19 Vaccine Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Oral COVID-19 Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Oral COVID-19 Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Oral COVID-19 Vaccine Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Oral COVID-19 Vaccine Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Oral COVID-19 Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Oral COVID-19 Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Oral COVID-19 Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Oral COVID-19 Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Oral COVID-19 Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Oral COVID-19 Vaccine Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Oral COVID-19 Vaccine Sales by Country (2024-2029) & (K Units)
Table 60. Europe Oral COVID-19 Vaccine Sales by Type (2018-2024) & (K Units)
Table 61. Europe Oral COVID-19 Vaccine Sales by Type (2024-2029) & (K Units)
Table 62. Europe Oral COVID-19 Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Oral COVID-19 Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Oral COVID-19 Vaccine Sales by Application (2018-2024) & (K Units)
Table 65. Europe Oral COVID-19 Vaccine Sales by Application (2024-2029) & (K Units)
Table 66. Europe Oral COVID-19 Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Oral COVID-19 Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Oral COVID-19 Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Oral COVID-19 Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Oral COVID-19 Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Oral COVID-19 Vaccine Sales by Country (2018-2024) & (K Units)
Table 72. Europe Oral COVID-19 Vaccine Sales by Country (2024-2029) & (K Units)
Table 73. China Oral COVID-19 Vaccine Sales by Type (2018-2024) & (K Units)
Table 74. China Oral COVID-19 Vaccine Sales by Type (2024-2029) & (K Units)
Table 75. China Oral COVID-19 Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Oral COVID-19 Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Oral COVID-19 Vaccine Sales by Application (2018-2024) & (K Units)
Table 78. China Oral COVID-19 Vaccine Sales by Application (2024-2029) & (K Units)
Table 79. China Oral COVID-19 Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Oral COVID-19 Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Oral COVID-19 Vaccine Sales by Type (2018-2024) & (K Units)
Table 82. Asia Oral COVID-19 Vaccine Sales by Type (2024-2029) & (K Units)
Table 83. Asia Oral COVID-19 Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Oral COVID-19 Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Oral COVID-19 Vaccine Sales by Application (2018-2024) & (K Units)
Table 86. Asia Oral COVID-19 Vaccine Sales by Application (2024-2029) & (K Units)
Table 87. Asia Oral COVID-19 Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Oral COVID-19 Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Oral COVID-19 Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Oral COVID-19 Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Oral COVID-19 Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Oral COVID-19 Vaccine Sales by Region (2018-2024) & (K Units)
Table 93. Asia Oral COVID-19 Vaccine Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Oral COVID-19 Vaccine Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Oral COVID-19 Vaccine Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Oral COVID-19 Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Oral COVID-19 Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Oral COVID-19 Vaccine Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Oral COVID-19 Vaccine Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Oral COVID-19 Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Oral COVID-19 Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Oral COVID-19 Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Oral COVID-19 Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Oral COVID-19 Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Oral COVID-19 Vaccine Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Oral COVID-19 Vaccine Sales by Country (2024-2029) & (K Units)
Table 107. Pfizer Company Information
Table 108. Pfizer Description and Major Businesses
Table 109. Pfizer Oral COVID-19 Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Pfizer Oral COVID-19 Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Pfizer Recent Developments
Table 112. CanSino Biologics Company Information
Table 113. CanSino Biologics Description and Major Businesses
Table 114. CanSino Biologics Oral COVID-19 Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. CanSino Biologics Oral COVID-19 Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. CanSino Biologics Recent Developments
Table 117. Kindred Biosciences, Inc. Company Information
Table 118. Kindred Biosciences, Inc. Description and Major Businesses
Table 119. Kindred Biosciences, Inc. Oral COVID-19 Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Kindred Biosciences, Inc. Oral COVID-19 Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Kindred Biosciences, Inc. Recent Developments
Table 122. Zhejiang Huahai Pharmaceutical Co.,ltd. Company Information
Table 123. Zhejiang Huahai Pharmaceutical Co.,ltd. Description and Major Businesses
Table 124. Zhejiang Huahai Pharmaceutical Co.,ltd. Oral COVID-19 Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Zhejiang Huahai Pharmaceutical Co.,ltd. Oral COVID-19 Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Zhejiang Huahai Pharmaceutical Co.,ltd. Recent Developments
Table 127. Shandong Xinhua Pharmaceutical Company Information
Table 128. Shandong Xinhua Pharmaceutical Description and Major Businesses
Table 129. Shandong Xinhua Pharmaceutical Oral COVID-19 Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. Shandong Xinhua Pharmaceutical Oral COVID-19 Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Shandong Xinhua Pharmaceutical Recent Developments
Table 132. Kintor Pharmaceutical Company Information
Table 133. Kintor Pharmaceutical Description and Major Businesses
Table 134. Kintor Pharmaceutical Oral COVID-19 Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. Kintor Pharmaceutical Oral COVID-19 Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Kintor Pharmaceutical Recent Developments
Table 137. Henan Genuine Biotech Co., Ltd. Company Information
Table 138. Henan Genuine Biotech Co., Ltd. Description and Major Businesses
Table 139. Henan Genuine Biotech Co., Ltd. Oral COVID-19 Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. Henan Genuine Biotech Co., Ltd. Oral COVID-19 Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Henan Genuine Biotech Co., Ltd. Recent Developments
Table 142. Key Raw Materials Lists
Table 143. Raw Materials Key Suppliers Lists
Table 144. Oral COVID-19 Vaccine Distributors List
Table 145. Oral COVID-19 Vaccine Customers List
Table 146. Oral COVID-19 Vaccine Market Trends
Table 147. Oral COVID-19 Vaccine Market Drivers
Table 148. Oral COVID-19 Vaccine Market Challenges
Table 149. Oral COVID-19 Vaccine Market Restraints
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Oral COVID-19 Vaccine Product Picture
Figure 2. Global Oral COVID-19 Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Oral COVID-19 Vaccine Market Share by Type in 2022 & 2029
Figure 4. Tablet Type Product Picture
Figure 5. Inhalable Type Product Picture
Figure 6. Global Oral COVID-19 Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Oral COVID-19 Vaccine Market Share by Application in 2022 & 2029
Figure 8. Adults
Figure 9. Children
Figure 10. Elderly
Figure 11. Oral COVID-19 Vaccine Report Years Considered
Figure 12. Global Oral COVID-19 Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Oral COVID-19 Vaccine Revenue 2018-2029 (US$ Million)
Figure 14. Global Oral COVID-19 Vaccine Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global Oral COVID-19 Vaccine Revenue Market Share by Region (2018-2029)
Figure 16. Global Oral COVID-19 Vaccine Sales 2018-2029 ((K Units)
Figure 17. Global Oral COVID-19 Vaccine Sales Market Share by Region (2018-2029)
Figure 18. US & Canada Oral COVID-19 Vaccine Sales YoY (2018-2029) & (K Units)
Figure 19. US & Canada Oral COVID-19 Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 20. Europe Oral COVID-19 Vaccine Sales YoY (2018-2029) & (K Units)
Figure 21. Europe Oral COVID-19 Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 22. China Oral COVID-19 Vaccine Sales YoY (2018-2029) & (K Units)
Figure 23. China Oral COVID-19 Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Asia (excluding China) Oral COVID-19 Vaccine Sales YoY (2018-2029) & (K Units)
Figure 25. Asia (excluding China) Oral COVID-19 Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Oral COVID-19 Vaccine Sales YoY (2018-2029) & (K Units)
Figure 27. Middle East, Africa and Latin America Oral COVID-19 Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 28. The Oral COVID-19 Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Oral COVID-19 Vaccine in the World: Market Share by Oral COVID-19 Vaccine Revenue in 2022
Figure 30. Global Oral COVID-19 Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Oral COVID-19 Vaccine Sales Market Share by Type (2018-2029)
Figure 32. Global Oral COVID-19 Vaccine Revenue Market Share by Type (2018-2029)
Figure 33. Global Oral COVID-19 Vaccine Sales Market Share by Application (2018-2029)
Figure 34. Global Oral COVID-19 Vaccine Revenue Market Share by Application (2018-2029)
Figure 35. US & Canada Oral COVID-19 Vaccine Sales Market Share by Type (2018-2029)
Figure 36. US & Canada Oral COVID-19 Vaccine Revenue Market Share by Type (2018-2029)
Figure 37. US & Canada Oral COVID-19 Vaccine Sales Market Share by Application (2018-2029)
Figure 38. US & Canada Oral COVID-19 Vaccine Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Oral COVID-19 Vaccine Revenue Share by Country (2018-2029)
Figure 40. US & Canada Oral COVID-19 Vaccine Sales Share by Country (2018-2029)
Figure 41. U.S. Oral COVID-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 42. Canada Oral COVID-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 43. Europe Oral COVID-19 Vaccine Sales Market Share by Type (2018-2029)
Figure 44. Europe Oral COVID-19 Vaccine Revenue Market Share by Type (2018-2029)
Figure 45. Europe Oral COVID-19 Vaccine Sales Market Share by Application (2018-2029)
Figure 46. Europe Oral COVID-19 Vaccine Revenue Market Share by Application (2018-2029)
Figure 47. Europe Oral COVID-19 Vaccine Revenue Share by Country (2018-2029)
Figure 48. Europe Oral COVID-19 Vaccine Sales Share by Country (2018-2029)
Figure 49. Germany Oral COVID-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 50. France Oral COVID-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 51. U.K. Oral COVID-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 52. Italy Oral COVID-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 53. Russia Oral COVID-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 54. China Oral COVID-19 Vaccine Sales Market Share by Type (2018-2029)
Figure 55. China Oral COVID-19 Vaccine Revenue Market Share by Type (2018-2029)
Figure 56. China Oral COVID-19 Vaccine Sales Market Share by Application (2018-2029)
Figure 57. China Oral COVID-19 Vaccine Revenue Market Share by Application (2018-2029)
Figure 58. Asia Oral COVID-19 Vaccine Sales Market Share by Type (2018-2029)
Figure 59. Asia Oral COVID-19 Vaccine Revenue Market Share by Type (2018-2029)
Figure 60. Asia Oral COVID-19 Vaccine Sales Market Share by Application (2018-2029)
Figure 61. Asia Oral COVID-19 Vaccine Revenue Market Share by Application (2018-2029)
Figure 62. Asia Oral COVID-19 Vaccine Revenue Share by Region (2018-2029)
Figure 63. Asia Oral COVID-19 Vaccine Sales Share by Region (2018-2029)
Figure 64. Japan Oral COVID-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 65. South Korea Oral COVID-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 66. China Taiwan Oral COVID-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 67. Southeast Asia Oral COVID-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 68. India Oral COVID-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Oral COVID-19 Vaccine Sales Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Oral COVID-19 Vaccine Revenue Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Oral COVID-19 Vaccine Sales Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Oral COVID-19 Vaccine Revenue Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Oral COVID-19 Vaccine Revenue Share by Country (2018-2029)
Figure 74. Middle East, Africa and Latin America Oral COVID-19 Vaccine Sales Share by Country (2018-2029)
Figure 75. Brazil Oral COVID-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 76. Mexico Oral COVID-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 77. Turkey Oral COVID-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 78. Israel Oral COVID-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 79. GCC Countries Oral COVID-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 80. Oral COVID-19 Vaccine Value Chain
Figure 81. Oral COVID-19 Vaccine Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries